| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243955 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 12 Pages |
Abstract
Conclusions: Radiation therapy for prostate carcinoma causes persistent GI toxicity that is largely independent of the two dose schedules. The hypofractionated schedule is equivalent in efficacy to the conventional schedule.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Eric E. M.D., F.R.C.P. (Edin), F.R.C.R., Richard H. M.D., F.R.A.C.P., Robert J. Ph.D., F.R.A.C.P., Rochelle J. B.Sc. (Hons), Addolorata C. B.Sc. (Hons), Julie Butters, Sujeeva M.D., Prasad M.D.,